학술논문
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study.
Document Type
Article
Author
Özdemir, Özlem; Zengel, Baha; Yildiz, Yaşar; Uluç, Basak Oyan; Cabuk, Devrim; Ozden, Ercan; Salim, Derya Kivrak; Paydas, Semra; Demir, Atakan; Diker, Omer; Pilanci, Kezban Nur; Sönmez, Özlem Uysal; Vatansever, Sezai; Dogan, Izzet; Gulmez, Ahmet; Cakar, Burcu; Gursoy, Pinar; Yildirim, Mahmut Emre; Ayhan, Murat; Karadurmus, Nuri
Source
Anti-Cancer Drugs; Aug2022, Vol. 33 Issue 7, p663-670, 8p
Subject
Language
ISSN
09594973